ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Fichet-Calvet E, Rogers DJ, 2009. Risk maps of Lassa fever in west Africa. PLoS Negl Trop Dis 3: e388.
-
2.
McCormick JB, Webb PA, Krebs JW, Johnson KM, Smith ES, 1987. A prospective study of the epidemiology and ecology of Lassa fever. J Infect Dis 155: 437–444.
-
3.
Knobloch J, McCormick JB, Webb PA, Dietrich M, Schumacher HH, Dennis E, 1980. Clinical observations in 42 patients with Lassa fever. Tropenmed Parasitol 31: 389–398.
-
4.
McCormick JB, King IJ, Webb PA, Johnson KM, O’Sullivan R, Smith ES, Trippel S, Tong TC, 1987. A case-control study of the clinical diagnosis and course of Lassa fever. J Infect Dis 155: 445–455.
-
5.
McCormick JB, Fisher-Hoch SP, 2002. Lassa fever. Curr Top Microbiol Immunol 262: 75–109.
-
6.
Shaffer JG et al. Viral Hemorrhagic Fever Consortium, 2014. Lassa fever in post-conflict Sierra Leone. PLoS Negl Trop Dis 8: e2748.
-
7.
Lukashevich IS, 2013. The search for animal models for Lassa fever vaccine development. Expert Rev Vaccines 12: 71–86.
-
8.
McCormick JB, King IJ, Webb PA, Scribner CL, Craven RB, Johnson KM, Elliott LH, Belmont-Williams R, 1986. Lassa fever. Effective therapy with ribavirin. N Engl J Med 314: 20–26.
-
9.
Monath TP, Newhouse VF, Kemp GE, Setzer HW, Cacciapuoti A, 1974. Lassa virus isolation from Mastomys natalensis rodents during an epidemic in Sierra Leone. Science 185: 263–265.
-
10.
Frame JD, Baldwin JR, Gocke DJ, Troup JM, 1970. Lassa fever, a new virus disease of man from west Africa. I. Clinical description and pathological findings. Am J Trop Med Hyg 19: 670–676.
-
11.
Macher AM, Wolfe MS, 2006. Historical Lassa fever reports and 30-year clinical update. Emerg Infect Dis 12: 835–837.
-
12.
Amorosa V et al. 2010. Imported Lassa fever, Pennsylvania, USA, 2010. Emerg Infect Dis 16: 1598–1600.
-
13.
CDC, 2014. Lassa Fever Reported in U.S. Traveler Returning from West Africa. Atlanta, GA: Centers for Disease Control and Prevention. Available at: http://www.cdc.gov/media/releases/2014/p0404-lassa-fever.html. Accessed February 28, 2017.
-
14.
Vieth S et al. 2007. RT-PCR assay for detection of Lassa virus and related old world arenaviruses targeting the L gene. Trans R Soc Trop Med Hyg 101: 1253–1264.
-
15.
Olschläger S, Lelke M, Emmerich P, Panning M, Drosten C, Hass M, Asogun D, Ehichioya D, Omilabu S, Günther S, 2010. Improved detection of Lassa virus by reverse transcription-PCR targeting the 5′ region of S RNA. J Clin Microbiol 48: 2009–2013.
-
16.
CDC, 2015. Guidance for Safe Handling of Human Remains of Ebola Patients in U.S. Hospitals and Mortuaries. Atlanta, GA: Centers for Disease Control and Prevention. Available at: http://www.cdc.gov/vhf/ebola/healthcare-us/hospitals/handling-human-remains.html. Accessed February 28, 2017.
-
17.
Bausch DG, Hadi CM, Khan SH, Lertora JJ, 2010. Review of the literature and proposed guidelines for the use of oral ribavirin as postexposure prophylaxis for Lassa fever. Clin Infect Dis 51: 1435–1441.
-
18.
CDC, 2015. U.S. Healthcare Workers and Settings. Atlanta, GA: Centers for Disease Control and Prevention. Available at: http://www.cdc.gov/vhf/ebola/healthcare-us/index.html. Accessed February 28, 2017.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 6 | 6 | 6 |
| Full Text Views | 761 | 168 | 8 |
| PDF Downloads | 241 | 68 | 5 |
Case Report: Imported Case of Lassa Fever — New Jersey, May 2015
We report a fatal case of Lassa fever diagnosed in the United States in a Liberian traveler. We describe infection control protocols and public health response. One contact at high risk became symptomatic, but her samples tested negative for Lassa virus; no secondary cases occurred among health care, family, and community contacts.
Author Notes
Financial support: This work was supported by the Centers for Disease Control and Prevention and the New Jersey Department of Health.
Authors’ addresses: Prathit A. Kulkarni, Communicable Disease Service, New Jersey Department of Health, Trenton, NJ, and Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, E-mail: pakulkar@bcm.edu. Debra Chew and David Cennimo, Infectious Diseases Section, Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ, and University Hospital, Newark, NJ, E-mails: chewde@njms.rutgers.edu and cennimda@njms.rutgers.edu. Manal Youssef-Bessler and Frantz Pierre-Louis, St. Barnabas Medical Center, Livingston, NJ, E-mails: manalmd@aol.com and frantzjr@gmail.com. Hanaa A. Hamdi and Atif Nazir, Newark Department of Health and Community Wellness, Newark, NJ, E-mails: hanaa.hamdi@tpl.org and atifho@gmail.com. Lindsay A. Montoya, Kimberly B. Cervantes, Nicole L. Mazur, Diana Lucas, Julia W. Wells, and Edward I. Lifshitz, Communicable Disease Service, New Jersey Department of Health, Trenton, NJ, E-mails: lahamilton90@gmail.com, kim.cervantes@doh.nj.gov, nicole.mazur@doh.nj.gov, diana.lucas@doh.nj.gov, julia.wells@doh.nj.gov, and edward.lifshitz@doh.nj.gov. Anne Sutherland, Pulmonary and Critical Care Medicine Section, Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ, and University Hospital, Newark, NY, E-mail: aks199@njms.rutgers.edu. Linda M. Di Domenico, Department of Infection Prevention and Control, University Hospital, Newark, NJ, E-mail: linda_didomenico@bshsi.org. Lincoln P. Miller, St. Barnabas Medical Center, Livingston, NJ, E-mail: millerlpnyc@aol.com. Gregory Rokosz, Department of Medical and Academic Affairs, St. Barnabas Medical Center, Livingston, NJ, E-mail: gregory.rokosz@rwjbh.org. Marie A. de Perio and Kenneth R. Mead, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, Cincinnati, OH, E-mails: mdeperio@cdc.gov and kmead@cdc.gov. Luis Lowe, Department of State and Local Readiness, Centers for Disease Control and Prevention, Atlanta, GA, E-mail: llowe@cdc.gov. Craig Manning, César G. Albariño, Ute Ströher, and Pierre E. Rollin, Viral Special Pathogens Branch, Centers for Disease Control and Prevention, Atlanta, GA, E-mails: craigrmanning@gmail.com, calbarino@cdc.gov, ute.stroeher@gmail.com, and prollin@cdc.gov. Bryan E. Christensen, Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, GA, E-mail: bchristensen@cdc.gov. Maleeka Glover, Office of Public Health Preparedness and Response, Centers for Disease Control and Prevention, Atlanta, GA, E-mail: mglover@cdc.gov. Christina G. Tan, Division of Epidemiology, Environmental and Occupational Health, New Jersey Department of Health, Trenton, NJ, E-mail: christina.tan@doh.nj.gov. Shereen Semple, Division of Public Health Infrastructure, Laboratories and Emergency Preparedness, New Jersey Department of Health, Trenton, NJ, E-mail: shereen.semple@doh.nj.gov.